AGIO Stock Analysis: Buy, Sell, or Hold?
AGIO - Agios Pharmaceuticals, Inc.
$37.58
0.50 (1.35%)
▲
5d:
+3.81%
30d:
+41.76%
90d:
+9.92%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 30, 2026
26d
Get Alerted When AGIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: AGIO is 11.8% above its trading range ($33.62). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: AGIO is 11.8% above its trading range ($33.62). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: AGIO is currently trading at $37.58, which is considered extended relative to its 30-day fair value range of $27.23 to $33.62.
Technical Outlook: Technically, AGIO is in a uptrend. The price is approaching resistance at $38.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AGIO is in a uptrend. The price is approaching resistance at $38.38. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$27.23 -
$33.62
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+11.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($40.75)
Trading Range Analysis
30-Day Trading Range
$27.23 -
$33.62
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$33.50
Resistance Level
$38.38
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.88
Wall Street Target
$40.75
(+8.4%)
Revenue Growth (YoY)
137.7%
Share & Embed Analysis
Last updated: July 02, 2026 10:43 PM ET
Data refreshes hourly during market hours. Next update: 11:43 PM
Data refreshes hourly during market hours. Next update: 11:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGIO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
James William Burns
SELL
3280 shares
2026-04-02
Sarah Gheuens
SELL
2940 shares
2026-04-02
Tsveta Milanova
SELL
3262 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 61 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 62 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
